Skip to Main Content

Paper Details

Bepotastine Sensitizes Ovarian Cancer to PARP Inhibitors through Suppressing NF-κB-Triggered SASP in Cancer-Associated Fibroblasts.
Mol Cancer Ther
4
2023
Author NameAffiliation
Zhen WangTongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Zhen WangNational Clinical Research Center for Obstetrics and Gynecology, Cancer Biology Research Center (Key Laboratory of the Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
  • 1 - 2

Datasets

Release 1.2